Subing Subing, Narcife .
HRN: 18-88-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2023
CEFUROXIME 500MG (TAB)
02/26/2023
03/05/2023
PO
500mg Tab
BID
S/P NSVD With RMLE And Repair
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes